Published on Medical Design Technology (https://www.mdtmag.com)

Home > Prostate cancer: Intuitive Surgical CEO Guthart on testing and "watchful waiting"

Prostate cancer: Intuitive Surgical CEO Guthart on testing and "watchful waiting"

In this exclusive interview with MassDevice, Intuitive Surgical president & CEO Gary Guthart weighs in on shifts in the prostate surgery conversation and recent controversies over the benefits of testing and aggressive prostate cancer treatment.

Gary Guthart Intuitive Surgical robot assisted surgery

Intuitive Surgical [1] (NSDQ:ISRG [2]) president & CEO Gary Guthart doesn't believe in taking a passive approach to men's health.

The increasingly heated conversation around the proper role of prostate cancer testing has played a big part in dragging down the market, which in turn has taken a toll on Intuitive's numbers. But the debate can be framed rather simply from a patient perspective.

"I would rather know than not know," Guthart told MassDevice.com during an exclusive meeting at the medical device company's Sunnyvale, Calif., headquarters yesterday. "The hear no evil, see no evil, see no evil strategy doesn't seem like a healthcare strategy to me."

Content Item Type: 
News [3]
Meta Canonical URL: 
http://www.mdtmag.com/news/2012/07/prostate-cancer-intuitive-surgical-ceo-guthart-testing-and-watchful-waiting
Summary: 
In this exclusive interview with MassDevice, Intuitive Surgical president & CEO Gary Guthart weighs in on shifts in the prostate surgery conversation and recent controversies over the benefits of testing and aggressive prostate cancer treatment. Intuitive Surgical (NSDQ:ISRG) president & CEO Gary Guthart doesn't believe in taking a passive approach to men's health. News Well, Oncology, Prostate, Research & Development, Robotic Assisted Surgeryread more
Contributed Author: 
Mass Device
Legacy NID: 
112 191

Deeper Insights

<% if ( rc.ss_related_image_url != null ){ %>
?cmpid=regwallcontent&utm_source=Deeper%20Insights">">
<% } %>

?cmpid=regwallcontent&utm_source=Deeper%20Insights" + ""><%- rc.label %>

<% if ( rc.ss_search_logo != null ){ %> <% } %>
Advertisement
googletag.cmd.push(function() { googletag.display("dfp-ad-clone_of_wallpaper"); });
(function() { var _fbq = window._fbq || (window._fbq = []); if (!_fbq.loaded) { var fbds = document.createElement('script'); fbds.async = true; fbds.src = '//connect.facebook.net/en_US/fbds.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(fbds, s); _fbq.loaded = true; } _fbq.push(['addPixelId', '745881082149515']); })(); window._fbq = window._fbq || []; window._fbq.push(['track', 'PixelInitialized', {}]);
(function(d,s,i,r) { if (d.getElementById(i)){return;} var n=d.createElement(s),e=d.getElementsByTagName(s)[0]; n.id=i;n.src='//js.hs-analytics.net/analytics/'+(Math.ceil(new Date()/r)*r)+'/1743435.js'; e.parentNode.insertBefore(n, e); })(document,"script","hs-analytics",300000);
var _qevents = _qevents || []; (function() { var elem = document.createElement('script'); elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js"; elem.async = true; elem.type = "text/javascript"; var scpt = document.getElementsByTagName('script')[0]; scpt.parentNode.insertBefore(elem, scpt); })(); _qevents.push({ qacct:"p-jsEPJWTckjCbE" });
Quantcast
googletag.cmd.push(function () { googletag.display("dfp-ad-roadblock_modal"); });
googletag.cmd.push(function() { googletag.display("dfp-ad-roadblock_modal"); });
Source URL: https://www.mdtmag.com/news/2012/07/prostate-cancer-intuitive-surgical-ceo-guthart-testing-and-watchful-waiting

Links
[1] http://www.massdevice.com/company/intuitive-surgical-inc
[2] http://www.google.com/finance?q=isrg
[3] https://www.mdtmag.com/content-item-types/news